Simpler Grants.gov #PAR-25-141

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

The National Institutes of Health (NIH) is inviting applications for the NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required), supporting research in arthritis, musculoskeletal, and skin diseases. - Government Buyer: - National Institutes of Health (NIH), specifically the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - Opportunity Details: - Funding instrument: Cooperative agreement (UG3/UH3) - Focus: Implementation of clinical trials in relevant disease areas - Assistance Listing: 93.846 - This is a re-issue with changes only to the application review process - Eligibility: - Open to educational institutions, government entities, businesses, nonprofits, tribal organizations, and minority-serving institutions - No cost sharing or matching required - Products/Services Requested: - No specific OEMs, vendors, products, or purchase quantities are identified - This is a grant opportunity for clinical trial implementation, not a procurement of goods or commercial services - Unique Requirements: - Applicants must propose clinical trials in the specified research areas - The opportunity is discretionary and supports a broad range of eligible organizations

Description

This funding opportunity is a cooperative agreement issued by the National Institutes of Health for the implementation of clinical trials under the NIAMS program. It is a re-issue of a previous announcement with changes only to the application review process. Eligible applicants include a wide range of educational institutions, government entities, businesses, nonprofits, and other organizations. The award does not require cost sharing or matching and is categorized under health discretionary funding.

View original listing